Symbio Research
Rekaut Naderipour is a seasoned clinical research professional with extensive experience in various roles within the industry since June 2018. Currently serving as a Senior Freelance CRA, CPM, and Director at RecQ Clinical Oy, Rekaut's consultancy focuses on training the next generation of clinical research associates in Finland while supporting ten freelancers in the region. Additional roles include Senior Freelance Clinical Research Associate at UBC and Allucent, with a cross-national focus on rare diseases and gastrointestinal disorders across Finland, Denmark, Germany, Norway, and the United Kingdom. Rekaut also holds a position as a Lecturer at the University of Helsinki, shares expertise as a Senior Clinical Research Specialist in EMEA at Medtronic, and leads site optimization efforts at Innovative Trials. The executive leadership experience includes serving as Chief Executive Officer at both RecQ Oy and Kameramiehet Oy and a prior role as Contract Local Study Associate Director at AstraZeneca, focusing on key therapeutic areas. Educational pursuits include ongoing studies at the University of Helsinki, University of Warwick, and University of Greenwich.
This person is not in the org chart
This person is not in any offices
Symbio Research
Headquartered in Port Jefferson, NY, Symbio is a client-focused global full service Clinical Research Organization (CRO). We manage all CRO core services in house and have our offices in the USA and Europe. We deliver excellent service and provide experienced qualified personnel to strategically manage all aspects of your clinical trials. Symbio offers expertise in Proof-of-Concept, medical device and Phase I – Phase IV clinical studies and has completed over 115 clinical studies to date, both in the USA and in other territories. Developing and maintaining excellent relationships with experienced clinical research sites are vital to the success of any study and every CRO. As a direct result of our site relationships, Symbio trials receive the special attention they deserve. We take great pride in the strong relationships we have established through the years. These relationships have provided us the ability to streamline recruitment, creating shorter enrollment timelines with a lower number of sites. Our expertise starts from the top. Symbio, LLC was founded in 2002 by Richard Panico and Debra Dow. With previous leadership roles in CRO management and product development, Rich and Deb have been able to successfully grow their company by carefully selecting qualified clinical research professionals. In collaboration with senior management, their continued oversight offers clients a personalized experience ensuring study management challenges are anticipated, identified and resolved quickly and efficiently. In 2018 Richard Panico, Debra Dow and Veronika Kunert founded Symbio’s subsidiary in Europe to support our clients with their global clinical trials. The vision from the start has been to create a CRO that consistently delivers outstanding service and quality to sponsors. The common goal is to bring clinical studies to a successful end, on time and on budget.